Collateral for a security interest recorded Jan 17, 2025 (Alter Domus (US) LLC, as Successor Collateral Agent).
Term ends Sep 5, 2028 · High confidence
20-year base term ended Apr 4, 2025
Held by Finthrive Healthcare, Inc.
Filed Apr 4, 2005 as application 11/098,295 · Granted Aug 17, 2010
Base term plus 1250 days of patent term adjustment (USPTO delay)
Today
2005
2028
Clock starts
Apr 4, 2005
Apr 4, 2005
Term ends
Sep 5, 2028
Sep 5, 2028
Granted
Aug 17, 2010
Aug 17, 2010
base term
patent term adjustment
fee events
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,250
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1250 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 4, 2005, when this application, 11/098,295, was filed | Apr 4, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1250 days, USPTO patent term adjustment record | Sep 5, 2028 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 5, 2028 | High confidence |
This family
| US 7,778,850 | this patent Sep 2028 | Sep 2028 |
| US 7,797,165 | In force no later than Feb 2027 | no later than Feb 2027 |
| US 8,204,762 | Term ended Apr 2025 | Apr 2025 |
| US 8,326,656 | Term ended Aug 2025 | Aug 2025 |
| US 8,433,586 | Term ended Apr 2025 | Apr 2025 |
| Application 13/692,664 | Abandoned not computed | not computed |
| Application 13/872,893 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 4, 2005 Reel 16450, frame 792 | Wester, John | E-Scan Data Systems | Assignment of Assignor's Interest |
| Mar 21, 2014 Reel 32500, frame 614 | E-Scan Data Systems, Inc. | Deutsche Bank Trust Company Americas, as Collateral Agent | Security Interest |
| Apr 25, 2014 Reel 32763, frame 217 | Deutsche Bank Trust Company Americas, as Withdrawing Administrative Agent and Collateral Agent | Deutsche Bank AG New York Branch, as New Administrative Agent and Collateral Agent | Assignment of Intellectual Property Security Agreement |
| Apr 29, 2016 Reel 38421, frame 912 | Transunion Healthcare LLC; Financial Healthcare Systems, LLC; E-Scan Data Systems, Inc. | Transunion Healthcare, Inc. | Merger and Change of Name |
| Dec 1, 2021 Reel 58294, frame 161 | Ebureau, LLC; Iovation, Inc.; Signal Digital, Inc.; Trans Union LLC; Transunion Healthcare, Inc.; Transunion Interactive, Inc.; Transunion Rental Screening Solutions, Inc.; Transunion Teledata LLC; Aggregate Knowledge, LLC; Tru Optik Data Corp.; Neustar Information Services, Inc.; Trustid, Inc.; Neustar, Inc.; Neustar IP Intelligence, Inc.; Marketshare Partners, LLC; Sontiq, Inc. | Jpmorgan Chase Bank, N.a | Grant of Security Interest in United States Patents |
| Dec 17, 2021 Reel 58537, frame 820 | Transunion Healthcare, Inc.; Nthrive Revenue Systems, LLC; Equation Consulting, LLC; Nthrive, Inc. | Jpmorgan Chase Bank, N.a. | First Lien Intellectual Property Security Agreement |
| Dec 17, 2021 Reel 58537, frame 853 | Transunion Healthcare, Inc.; Nthrive Revenue Systems, LLC; Equation Consulting, LLC; Nthrive, Inc. | Deutsche Bank AG New York Branch | Second Lien Intellectual Property Security Agreement |
| Dec 20, 2021 Reel 58549, frame 295 | Deutsche Bank AG New York Branch, as a Collateral Agent | Transunion Healthcare, Inc. | Termination and Release of Security Interest in Patents at Reel 032500, Frame 0543 and Reel 032500, Frame 0614 |
| Dec 27, 2021 Reel 58588, frame 173 | JPMorgan Chase Bank, N.A., as a Collateral Agent | Transunion Healthcare, Inc. | Termination and Release of Security Interest in Patents Recorded at Reel 058294, Frame 0161 |
| Sep 23, 2024 Reel 69024, frame 791 | Transunion Healthcare, Inc. | Finthrive Healthcare, Inc. | Change of Name |
| Nov 19, 2024 Reel 69387, frame 613 | Finthrive Healthcare, Inc.; Pelitas, LLC | Jpmorgan Chase Bank, N.a. | Superpriority Intellectual Property Security Agreement (PATENTS) |
| Jan 16, 2025 Reel 69933, frame 971 | JPMorgan Chase Bank, N.A., as Collateral Agent | Finthrive Healthcare, Inc. (F/K/A Transunion Healthcare, Inc.); Finthrive Revenue Systems, LLC (F/K/A Nthrive Revenue Systems, LLC); Equation Consulting, LLC; Finthrive, Inc. (F/K/A Nthrive, Inc.) | Termination and Release of First Lien Security Interest in Intellectual Property Recorded at Reel 058537, Frame 0820 |
| Jan 16, 2025 reel/frame not recorded | JPMorgan Chase Bank, N.A., as Collateral Agent | Finthrive Healthcare, Inc. (F/K/A Transunion Healthcare, Inc.) | Termination and Release of First Lien Security Interest in Intellectual Property Recorded at Reel 058537, Frame 0820 |
| Jan 16, 2025 reel/frame not recorded | JPMorgan Chase Bank, N.A., as Collateral Agent | Finthrive Revenue Systems, LLC (F/K/A Nthrive Revenue Systems, LLC) | Termination and Release of First Lien Security Interest in Intellectual Property Recorded at Reel 058537, Frame 0820 |
| Jan 16, 2025 reel/frame not recorded | JPMorgan Chase Bank, N.A., as Collateral Agent | Equation Consulting, LLC | Termination and Release of First Lien Security Interest in Intellectual Property Recorded at Reel 058537, Frame 0820 |
| Jan 16, 2025 reel/frame not recorded | JPMorgan Chase Bank, N.A., as Collateral Agent | Finthrive, Inc. (F/K/A Nthrive, Inc.) | Termination and Release of First Lien Security Interest in Intellectual Property Recorded at Reel 058537, Frame 0820 |
| Jan 17, 2025 Reel 69938, frame 461 | Deutsche Bank AG New York Branch, as Original Collateral Agent | Alter Domus (US) LLC, as Successor Collateral Agent | Assignment of Second Lien Intellectual Property Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2028
Term ends Sep 5, 2028. No further fees fall due before then
Note
The 1250 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
12
later US patents cite this one
That is above the median of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.